# Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study

Study · id `cardio:ct-nct03186404` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03186404](<https://clinicaltrials.gov/study/NCT03186404>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03186404

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 112 participants.

## Technical summary

Registry record NCT03186404. Randomized; quadruple masking; primary purpose prevention. Start 2018-05-10 (actual); primary completion 2021-12-21 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 112 participants (enrolled count; ClinicalTrials.gov record NCT03186404, source copy `cardio:ctgov-nct03186404-2022-02-08`, retrieved 2026-10-26)
- Started: 2018-05-10 (actual) (ClinicalTrials.gov record NCT03186404, source copy `cardio:ctgov-nct03186404-2022-02-08`, retrieved 2026-10-26)
- Primary completion: 2021-12-21 (actual) (ClinicalTrials.gov record NCT03186404, source copy `cardio:ctgov-nct03186404-2022-02-08`, retrieved 2026-10-26)
- Completion: 2023-12 (anticipated) (ClinicalTrials.gov record NCT03186404, source copy `cardio:ctgov-nct03186404-2022-02-08`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT03186404, source copy `cardio:ctgov-nct03186404-2022-02-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03186404-2022-02-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study
- Acronym: SPARE-HF
- Condition: Cancer
- Condition: Heart Failure
- Condition: Cardiotoxicity
- Intervention (Drug): Atorvastatin
- Intervention (Drug): Placebo oral tablet
- Lead sponsor: University Health Network, Toronto
- Lead sponsor class: OTHER
- Collaborator: Mount Sinai Hospital, Canada
- Collaborator class: OTHER
- Collaborator: Unity Health Toronto
- Collaborator class: OTHER
- Collaborator: Sunnybrook Health Sciences Centre
- Collaborator class: OTHER
- Collaborator: Scarborough General Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry intervention name matches this record: Atorvastatin (`cardio:atorvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: University Health Network, Toronto (`cardio:org-university-health-network-toronto`)
- Registry lists this organization as a collaborator: Mount Sinai Hospital, Canada (`cardio:org-mount-sinai-hospital-canada`)
- Registry lists this organization as a collaborator: Unity Health Toronto (`cardio:org-unity-health-toronto`)
- Registry lists this organization as a collaborator: Sunnybrook Health Sciences Centre (`cardio:org-sunnybrook-health-sciences-centre`)
- Registry lists this organization as a collaborator: Scarborough General Hospital (`cardio:org-scarborough-general-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines (`cardio:pubmed-37120736`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 36a3db0254fbe96c64722c0a63e41021915905fa0f7630b21a7398af872f9afc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
